| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multidisciplinary team-based approach with lifestyle modification and symptom management to address the impact of androgen deprivation therapy in prostate cancer: A randomized phase II study
|
Pollock, YaoYao
|
|
|
39 |
10 |
p. 730.e9-730.e15
|
artikel
|
| 2 |
Can preoperative renal mass biopsy change clinical practice and reduce surgical intervention for small renal masses?
|
Okhunov, Zhamshid
|
|
|
39 |
10 |
p. 735.e17-735.e23
|
artikel
|
| 3 |
Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with 225Ac-PSMA-617 targeted alpha-radiation therapy
|
van der Doelen, Maarten J.
|
|
|
39 |
10 |
p. 729.e7-729.e16
|
artikel
|
| 4 |
Comprehensive genomic profiling of histologic subtypes of urethral carcinomas
|
Jacob, Joseph
|
|
|
39 |
10 |
p. 731.e1-731.e15
|
artikel
|
| 5 |
Contribution of bladder cancer pathology assessment in planning clinical trials
|
Guo, Charles C.
|
|
|
39 |
10 |
p. 713-719
|
artikel
|
| 6 |
Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition vs. cisplatin-based chemotherapy in muscle invasive bladder cancer
|
Khaki, Ali Raza
|
|
|
39 |
10 |
p. 732.e9-732.e16
|
artikel
|
| 7 |
Current controversies on the role of lymphadenectomy for testicular cancer for the journal: Urologic Oncology: Seminars and Original Investigations for the special seminars section on the role of lymphadenectomy for urologic cancers
|
Masterson, Timothy A.
|
|
|
39 |
10 |
p. 698-703
|
artikel
|
| 8 |
Cyclophosphamide-associated bladder cancers and considerations for survivorship care: A systematic review
|
Chou, Wesley H.
|
|
|
39 |
10 |
p. 678-685
|
artikel
|
| 9 |
Designing lean, efficient clinical trials is an ethical imperative: the fragility index should not be used in the design of randomized clinical trials
|
Stensland, Kristian D
|
|
|
39 |
10 |
p. 738-739
|
artikel
|
| 10 |
Endoscopic exploration directly impacts clinical decision making in the management of patients with suspected upper tract urothelial carcinoma following radical cystectomy
|
Aumatell, Júlia
|
|
|
39 |
10 |
p. 732.e1-732.e8
|
artikel
|
| 11 |
High-intensity end-of-life care among Medicare beneficiaries with bladder cancer
|
Hugar, Lee A.
|
|
|
39 |
10 |
p. 731.e17-731.e24
|
artikel
|
| 12 |
How to manage patients with suspected upper tract urothelial carcinoma in the pandemic of COVID-19?
|
Lee, Hsiang-Ying
|
|
|
39 |
10 |
p. 733.e11-733.e16
|
artikel
|
| 13 |
Immunotherapy for metastatic renal cell carcinoma: A brief history, current trends, and future directions
|
Rambhia, Ami
|
|
|
39 |
10 |
p. 664-677
|
artikel
|
| 14 |
Impact of paclitaxel, cisplatin, and gemcitabine as first-line chemotherapy in cisplatin-fit and -unfit patients with advanced/metastatic urothelial carcinoma
|
Katayama, Satoshi
|
|
|
39 |
10 |
p. 731.e25-731.e32
|
artikel
|
| 15 |
Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand?
|
Basile, Giuseppe
|
|
|
39 |
10 |
p. 631-641
|
artikel
|
| 16 |
Letter to the Editor, Re: Reitblat et al. 2021
|
Williamson, Casey W.
|
|
|
39 |
10 |
p. 740-741
|
artikel
|
| 17 |
Letter to the editor Re: Shore ND, Palou Redorta J, Robert G, et al. Non-muscle-invasive bladder cancer: An overview of potential new treatment options. Urol oncol. Published online june 21, 2021:S1078-1439(21)00221-0
|
Feuer, Zachary
|
|
|
39 |
10 |
p. 737
|
artikel
|
| 18 |
Local anesthesia for percutaneous US/CT-guided bipolar radiofrequency ablation of small renal masses: A safe and feasible alternative
|
Sun, Yifan
|
|
|
39 |
10 |
p. 734.e19-734.e24
|
artikel
|
| 19 |
Management of anticoagulation and antiplatelet agents in the radical cystectomy patient
|
Smelser, Woodson W.
|
|
|
39 |
10 |
p. 691-697
|
artikel
|
| 20 |
Management of bone and metabolic effects of androgen deprivation therapy
|
Russell, Nicholas
|
|
|
39 |
10 |
p. 704-712
|
artikel
|
| 21 |
Mechanisms and markers of resistance to androgen signaling inhibitors in patients with metastatic castration-resistant prostate cancer
|
Csizmarik, Anita
|
|
|
39 |
10 |
p. 728.e13-728.e24
|
artikel
|
| 22 |
Molecular subtyping and immune-gene signatures identify a subset of early bladder tumors as candidates for single-agent immune-checkpoint inhibition
|
Necchi, Andrea
|
|
|
39 |
10 |
p. 734.e11-734.e17
|
artikel
|
| 23 |
New and topics: enfortumab vedotin mechanisms of response and resistance in urothelial cancer – What do we understand so far?
|
Hoffman-Censits, Jean
|
|
|
39 |
10 |
p. 619-622
|
artikel
|
| 24 |
Non-muscle-invasive bladder cancer: An overview of potential new treatment options
|
Shore, Neal D.
|
|
|
39 |
10 |
p. 642-663
|
artikel
|
| 25 |
Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years
|
Togashi, Kyo
|
|
|
39 |
10 |
p. 729.e17-729.e25
|
artikel
|
| 26 |
Optimizing androgen deprivation therapy with radiation therapy for aggressive localized and locally advanced prostate cancer
|
Yang, David D.
|
|
|
39 |
10 |
p. 720-727
|
artikel
|
| 27 |
PD-L1 expression in bladder cancer: Which scoring algorithm in what tissue?
|
Schulz, Gerald Bastian
|
|
|
39 |
10 |
p. 734.e1-734.e10
|
artikel
|
| 28 |
Penile-sparing surgery for patients with superficial or initially invasive squamous cell carcinoma of the penis: long-term oncological outcomes
|
Luzzago, Stefano
|
|
|
39 |
10 |
p. 736.e1-736.e7
|
artikel
|
| 29 |
Prognostic impact of immune-related adverse events in metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
|
Ikeda, Takashi
|
|
|
39 |
10 |
p. 735.e9-735.e16
|
artikel
|
| 30 |
Prognostic nutritional index and prognosis in renal cell carcinoma: A systematic review and meta-analysis
|
Kim, Sun Il
|
|
|
39 |
10 |
p. 623-630
|
artikel
|
| 31 |
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up
|
Barth, Dominik A.
|
|
|
39 |
10 |
p. 736.e9-736.e16
|
artikel
|
| 32 |
Prostate cancer active surveillance outcomes in a cohort composed primarily of African American and Hispanic American Men
|
Kidd, Laura C.
|
|
|
39 |
10 |
p. 730.e1-730.e8
|
artikel
|
| 33 |
Prostatic calcifications: Quantifying occurrence, radiodensity, and spatial distribution in prostate cancer patients
|
Singh, Saurabh
|
|
|
39 |
10 |
p. 728.e1-728.e6
|
artikel
|
| 34 |
Real-world burden of illness and unmet need in locally advanced or metastatic urothelial carcinoma following discontinuation of PD-1/L1 inhibitor therapy: A Medicare claims database analysis
|
Morgans, Alicia K.
|
|
|
39 |
10 |
p. 733.e1-733.e10
|
artikel
|
| 35 |
Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patients
|
Bloom, Jonathan B.
|
|
|
39 |
10 |
p. 729.e1-729.e6
|
artikel
|
| 36 |
Serum and urine biomarkers for detecting clinically significant prostate cancer
|
Becerra, Maria F.
|
|
|
39 |
10 |
p. 686-690
|
artikel
|
| 37 |
SPLIT RUN: D_83499_Myova_Orgov_SP_4C.p1.pdf [US only]
|
|
|
|
39 |
10 |
p. IFC
|
artikel
|
| 38 |
The additive value of mpMRI on prostate cancer detection: Comparison between patients with and without a suspicious digital rectal examination (DRE)
|
Omri, Nativ
|
|
|
39 |
10 |
p. 728.e7-728.e11
|
artikel
|
| 39 |
The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette–Guérin therapy for non-muscle invasive bladder cancer in a genome-wide association study
|
Nagakawa, Shohei
|
|
|
39 |
10 |
p. 733.e17-733.e24
|
artikel
|
| 40 |
Unilateral lesion detected on preoperative multiparametric magnetic resonance imaging and MRI/US fusion-guided prostate biopsy is not an appropriate indication for focal therapy in prostate cancer
|
Zhou, Zhien
|
|
|
39 |
10 |
p. 730.e17-730.e22
|
artikel
|
| 41 |
Urologic oncology randomized controlled trials are frequently fragile - A review of the urology literature
|
Chertin, Leon
|
|
|
39 |
10 |
p. 735.e1-735.e8
|
artikel
|
| 42 |
Urothelial carcinoma with trophoblastic differentiation: Reappraisal of the clinical implication and immunohistochemically features
|
Cheng, Hong-Ling
|
|
|
39 |
10 |
p. 732.e17-732.e23
|
artikel
|
Tijdschrift beschrijving